Literature DB >> 3189815

Quantification of gangliotetraose gangliosides with cholera toxin.

G S Wu1, R Ledeen.   

Abstract

A procedure is described for assay of GM1 and other gangliotetraose-type gangliosides at the picomole level. The gangliosides are absorbed onto polystyrene microwells and treated with neuraminidase and then with cholera toxin B subunits conjugated to horseradish peroxidase. Color is developed and quantified spectrophotometrically. Omission of neuraminidase gives a measure of GM1 alone. Linearity was obtained between 0.5 and 3 pmol. This procedure was applied to ganglioside mixtures isolated fron neuro-2A neuroblastoma and PC12 pheochromocytoma cells. For the latter, an additional step involving reaction with fucosidase increased the yield of GM1 due to the presence of fucosylated gangliosides. Application of the same reagents as a TLC overlay procedure to the gangliosides from neuro-2A cells revealed the presence of GD1a, GD1b, and GT1b in addition to GM1, thus confirming the presence of a family of gangliotetraose gangliosides.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3189815     DOI: 10.1016/0003-2697(88)90201-1

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  19 in total

1.  On the use of cholera toxin.

Authors:  Elena Chiricozzi; Laura Mauri; Maria Grazia Ciampa; Alessandro Prinetti; Sandro Sonnino
Journal:  Glycoconj J       Date:  2018-04-07       Impact factor: 2.916

2.  Ganglioside expression in tissues of mice lacking beta2-microglobulin.

Authors:  A Markotić; A Marusić; J Tomac; J Müthing
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

3.  The different inhibiting effect of cholera toxin on two leukemia cell lines does not correlate with their toxin binding capacity.

Authors:  A Giuliani; E Calappi; E Mineo; M G Neri; A Gallina; A Pessina
Journal:  Mol Cell Biochem       Date:  1995-11-22       Impact factor: 3.396

Review 4.  GM1 Ganglioside: Past Studies and Future Potential.

Authors:  Massimo Aureli; Laura Mauri; Maria Grazia Ciampa; Alessandro Prinetti; Gino Toffano; Cynthia Secchieri; Sandro Sonnino
Journal:  Mol Neurobiol       Date:  2015-03-12       Impact factor: 5.590

5.  The ganglioside GD1 alpha' IV3Neu5Ac, III6Neu5Ac-GgOse4Cer, is a major disialoganglioside in the highly metastatic murine lymphoreticular tumour cell line MDAY-D2.

Authors:  J Müthing; J Peter-Katalinić; F G Hanisch; F Unland; J Lehmann
Journal:  Glycoconj J       Date:  1994-04       Impact factor: 2.916

6.  Different binding capacities of influenza A and Sendai viruses to gangliosides from human granulocytes.

Authors:  J Müthing; F Unland; D Heitmann; M Orlich; F G Hanisch; J Peter-Katalinić; V Knäuper; H Tschesche; S Kelm; R Schauer
Journal:  Glycoconj J       Date:  1993-02       Impact factor: 2.916

7.  A novel ganglioside with a free amino group in bovine brain.

Authors:  K I Hidari; F Irie; M Suzuki; K Kon; S Ando; Y Hirabayashi
Journal:  Biochem J       Date:  1993-11-15       Impact factor: 3.857

8.  Ganglioside composition of subcellular fractions, including pre- and postsynaptic membranes, from Torpedo electric organ.

Authors:  R W Ledeen; M F Diebler; G Wu; Z H Lu; H Varoqui
Journal:  Neurochem Res       Date:  1993-11       Impact factor: 3.996

9.  Changes of the ganglioside pattern and content in human fibroblasts by high density cell population subculture progression.

Authors:  Mariateresa Sciannamblo; Vanna Chigorno; Alberto Passi; Rea Valaperta; Ileana Zucchi; Sandro Sonnino
Journal:  Glycoconj J       Date:  2002-03       Impact factor: 2.916

10.  Selection of a WEHI-3B leukemia cell subclone resistant to inhibition by cholera toxin.

Authors:  Augusto Pessina; Attilia Giuliani; Cristina Croera; Paola Foti; Lucia Mascolo; Giuseppina Gagliardi; Maria Grazia Neri
Journal:  Mol Cell Biochem       Date:  2002-04       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.